Skip to main content
C

COGSTATE LTD — Investor Relations & Filings

Ticker · CGS ISIN · AU000000CGS8 LEI · 254900VP9WAWA180NC18 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,416 across all filing types
Latest filing 2026-04-23 Transaction in Own Shar…
Country AU Australia
Listing ASX CGS

About COGSTATE LTD

https://www.cogstate.com

Cogstate Ltd is a neuroscience technology company specializing in the development and commercialization of digital brain health assessments. The company provides scientifically validated computerized cognitive tests designed to measure various domains of brain function, including memory, attention, and executive function. Its primary offerings include clinical trial services, where it supports pharmaceutical and biotechnology companies in the recruitment, monitoring, and data analysis of global studies, particularly in therapeutic areas such as Alzheimer’s disease and other neurodegenerative disorders. Additionally, Cogstate offers healthcare solutions for the early detection of cognitive impairment in clinical settings. The company’s technology is characterized by its sensitivity to change, cultural neutrality, and ease of administration across diverse populations, facilitating efficient and standardized cognitive monitoring in both research and clinical practice.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - CGS 6 pages 18.2KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C notification detailing Cogstate Ltd’s daily on-market buy-back of its ordinary shares, including quantities, prices, and schedules. This constitutes a report of the company buying back its own shares, matching the “Transaction in Own Shares” category (Code: POS).
2026-04-23 English
Update - Notification of buy-back - CGS 6 pages 18.3KB
Transaction in Own Shares Classification · 1% confidence The document is an ASX Appendix 3C daily notification of on-market share buy-back, detailing the number of securities purchased, prices paid, buy-back limits, dates, and broker. This clearly reports a company’s own share repurchase activity. According to the filing definitions, this corresponds to “Transaction in Own Shares (Code: POS).”
2026-04-22 English
Appointment of Non-Executive Director 2 pages 89.2KB
Board/Management Information Classification · 1% confidence The document is an ASX announcement titled “Appointment of Non-Executive Director” describing the appointment of a new board member and related committee changes. This clearly falls under Board/Management Information, which is Code MANG.
2026-04-22 English
Change of Director's Interest Notice - MM 5 pages 117.6KB
Director's Dealing Classification · 1% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” detailing a director’s personal securities transactions under listing rule 3.19A.2. It discloses quantities of shares acquired and disposed by the director and indirect interests, which is a classic insider dealing report. Therefore it is a Director’s Dealing notification.
2026-04-14 English
Notification of cessation of securities - CGS 5 pages 17.1KB
Regulatory Filings
2026-04-09 English
Application for quotation of securities - CGS 6 pages 18.5KB
Regulatory Filings
2026-04-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.